Wuhan Hiteck Biological Pharma Co.,Ltd
300683.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.46B
Close$
Share Statistics
| Market cap | $3.46 Billion |
|---|---|
| Enterprise Value | $3.34 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.77 |
| Beta | -0.33 |
| Outstanding Shares | 130,894,391 |
Return
| Return on Equity | -13.00% |
|---|---|
| Return on Assets | -10.96% |
| Return on Invested Capital | -12.82% |
Valuation & Multiples
| P/E Ratio | -12.65 |
|---|---|
| PEG | -10.5 |
| Price to Sales | 7.83 |
| Price to Book Ratio | 1.57 |
| Enterprise Value to Revenue | 6.79 |
| Enterprise Value to EBIT | -11.91 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Wuhan Hiteck Biological Pharma Co.,Ltd
958 employees
CEO: Wen Xian Wuhan Hiteck Biological Pharma Co.,Ltd is a biopharmaceutical enterprise operating in China, primarily engaged in the research, development, manufacturing, and commercialization of bio-engineered products and lyophilized injectable medic...